RCM
CRL icon

Rotella Capital Management’s Charles River Laboratories CRL Stock Holding History

Rotella Capital Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-5,100
Closed -$410K – 67
2015
Q4 		$410K Buy
+5,100
New +$368K 0.37% 122

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Rotella Capital Management's CRL Position: Q1 2016 in Review

Rotella Capital Management sold out of Charles River Laboratories (CRL) in Q1 2016, closing a stake of 5,100 shares — an estimated $410K sold.

Rotella Capital Management first reported a position in CRL in Q4 2015 and held it in 1 quarter. The position peaked at $410K in Q4 2015. 264 funds tracked by Wall St. Rank hold CRL as of Q1 2016.

  • Rotella Capital Management reported no remaining Charles River Laboratories position as of Q1 2016 after selling out during the quarter.
  • Rotella Capital Management sold 5,100 Charles River Laboratories shares in Q1 2016, an estimated $410K.
  • Rotella Capital Management first reported a position in Charles River Laboratories in Q4 2015 and held it in 1 quarter.
  • Rotella Capital Management's Charles River Laboratories position peaked at $410K in Q4 2015.
  • 264 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2016.

Based on Rotella Capital Management's 13F filing for Q1 2016, filed 13 May 2016.